Structure via PubChem · Public domain (PubChem)
cabergoline
Sign in to saveAlso known as Cabaser®, Caberlin®, (8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide, 1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea, 1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea, 1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea, (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide, (8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide
Cabergoline, sold under the brand name Dostinex among others, is a dopaminergic medication used in the treatment of high prolactin levels, prolactinomas, Parkinson's disease, and for other indications. It is taken by mouth.
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 477165198
- Drug.image
- Cabergoline Skeletal.png
- Drug.image_class
- skin-invert-image
- Drug.width
- 268
- Drug.image2
- Cabergoline_3D_Xtal_ballandstick.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 260
- Drug.tradename
- Dostinex, others
- Drug.DailyMedID
- Cabergoline
- Drug.routes_of_administration
- Oral
- Drug.ATC_prefix
- G02
- Drug.ATC_suffix
- CB03
- Drug.legal_AU
- S4
- Drug.legal_US
- Rx-only
- Drug.bioavailability
- 50–80%
- Drug.protein_bound
- Moderately bound (40–42%); concentration-independent
via Wikipedia infobox
Chemical data
- Formula
- C26H37N5O2
- Molecular weight
- 451.6 g/mol
- IUPAC name
- (6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
- SMILES
- CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C
- InChIKey
- KORNTPPJEAJQIU-KJXAQDMKSA-N
- XLogP
- 3.4
- Polar surface area
- 71.7 Ų
- H-bond donors
- 2
- H-bond acceptors
- 4
- Formal charge
- 0
via PubChem
Research
2,371 papers- Cabergoline in acromegaly.Pituitary · 2017
- Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy Loss: A Randomized Controlled Trial.Obstetrics and gynecology · 2023
- Cabergoline Use and Pregnancy Outcomes: A Systematic Review.Birth defects research · 2025
- Cabergoline: a review of its use in the inhibition of lactation for women living with HIV.Journal of the International AIDS Society · 2019
- Pituitary acting drugs: cabergoline and pasireotide.Pituitary · 2022
via PubMed
Wikidata facts
- Mass
- 451.294725
Show 6 more facts
- chemical formula
- C₂₆H₃₇N₅O₂
- canonical SMILES
- CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C
- isomeric SMILES
- CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C
- World Health Organisation international non-proprietary name
- cabergoline
- defined daily dose
- 0.5
- Commons category
- Cabergoline
via Wikidata · CC0
~14 min read
Article
17 sectionsContents
- Medical uses
- Off-label
- Pregnancy and lactation
- Contraindications
- Side effects
- Valvular heart disease
- Interactions
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- History
- Society and culture
- Brand names
- Research
- See also
- References
- External links
Cabergoline, sold under the brand name Dostinex among others, is a dopaminergic medication used in the treatment of high prolactin levels, prolactinomas, Parkinson's disease, and for other indications. It is taken by mouth.
Cabergoline is an ergot derivative and a potent dopamine D2 receptor agonist.